Glycolysis is the ten-step sequence of chemical reactions that breaks glucose down into two smaller molecules called pyruvate, producing a small but fast supply of usable energy along the way. It happens in the fluid interior of virtually every cell, does not require oxygen, and was the first complete metabolic pathway scientists ever mapped out. Research into how organisms break down sugar stretches back roughly three centuries, with the pathway eventually named for the work of Gustav Embden, Otto Meyerhof, and Jakub Karol Parnas.1ScienceDirect (Current Opinion in Systems Biology). Glycolysis: How a 300yr long research journey that started with the desire to improve alcoholic beverages kept revolutionizing biochemistry Despite its reputation as a “basic” topic in biology courses, glycolysis turns out to be far more nuanced and surprising than the textbook diagram suggests.
The Two Halves of the Pathway
Glycolysis splits neatly into an investment phase and a payoff phase. In the first half, the cell spends two molecules of ATP to rearrange and split one six-carbon glucose molecule into two three-carbon pieces. This upfront energy cost is what makes the early steps feel counterintuitive: you burn fuel to break down fuel. The key product of the investment phase is fructose-1,6-bisphosphate, which is then cleaved by an enzyme called aldolase into two three-carbon fragments.2PubMed Central. Multifunctional Fructose 1,6-Bisphosphate Aldolase as a Therapeutic Target
In the payoff phase, each of those three-carbon fragments is oxidized and rearranged through five more reactions, ultimately producing pyruvate. For every glucose molecule that enters, the payoff phase generates four ATP and two molecules of NADH, an electron carrier. After subtracting the two ATP spent upfront, the net gain is two ATP per glucose. That sounds modest compared to the roughly 30-plus ATP a cell can wring from glucose when oxygen is available for downstream processing, but the speed of glycolysis matters enormously. Cells that need energy fast, or cells in low-oxygen environments, lean on this pathway heavily.
Where the Speed Limits Are
Not every step in the pathway exerts equal control over how fast glucose gets processed. A systematic study that individually overexpressed 24 glycolysis-related genes in mammalian cells found that only seven of them meaningfully increased the rate of glucose breakdown. Those seven included glucose transporters (the proteins that pull glucose into the cell in the first place), phosphofructokinase (the enzyme that catalyzes the first committed step), and a lactate transporter that exports waste at the end.3Cell Systems. Systematic Analysis of Glycolytic Flux Control in Mammalian Cells Enzymes in the second half of the pathway, including pyruvate kinase and lactate dehydrogenase, had surprisingly little effect on overall throughput when boosted individually. In other words, the bottleneck sits at the top of the process: how much glucose gets into the cell and how quickly it passes through the committed gate.
Phosphofructokinase, the gatekeeper enzyme, responds to an elaborate set of signals from the rest of the cell. When fatty acids are abundant, long-chain fatty acyl-CoA molecules bind to it and shut it down, essentially telling glycolysis to slow because lipid fuels are already available.4PubMed Central. Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism Meanwhile, the molecule fructose-2,6-bisphosphate acts as one of the most potent activators, ramping the enzyme up when the cell needs more glycolytic output.5PubMed. Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo Low oxygen triggers increased production of this activator, which explains why cells in oxygen-poor tissue ramp up glycolysis automatically.
What Happens After Pyruvate
Glycolysis itself ends at pyruvate, but what happens next depends almost entirely on oxygen availability. When oxygen is plentiful, pyruvate enters the mitochondria and feeds into a longer series of reactions that extracts far more energy. When oxygen is scarce, or when the cell simply needs to keep glycolysis running at top speed, pyruvate is instead converted to lactate by an enzyme called lactate dehydrogenase. This conversion is not about making lactate for its own sake; its real purpose is to recycle NAD+, a molecule the pathway needs to keep operating. Without that recycling step, glycolysis stalls.
This recycling role is so critical that certain cancer cells die if their lactate dehydrogenase is blocked. Research in acute myeloid leukemia cells showed that inhibiting the enzyme caused the cellular pool of NAD+ to plummet, crippled glycolysis, and led to cell death. Artificially restoring NAD+ by other means rescued the cells, confirming that the essential job was maintaining NAD+ balance, not producing lactate per se.6PubMed Central. Lactate dehydrogenase A-coupled NAD(+) regeneration is critical for acute myeloid leukemia cell survival
Fermentation in yeast follows a similar logic but with a twist: pyruvate is converted to ethanol and carbon dioxide instead of lactate. The underlying point is the same. NAD+ gets regenerated so glycolysis can continue without oxygen.
Why Cancer Cells Love Glycolysis
In the 1920s, Otto Warburg noticed that cancer cells ferment glucose into lactate even when plenty of oxygen is available. This behavior, now called the Warburg effect, initially seemed wasteful. Why would a cell choose the pathway that nets only two ATP when the full oxygen-dependent route yields so much more? The emerging answer is that rapidly dividing cells are not optimizing for energy alone. They also need raw materials, the carbon skeletons from which new amino acids, lipids, and nucleotides are built. By running glycolysis at high speed and diverting intermediates into biosynthetic side-routes, proliferating cells generate the building blocks they need to construct a new cell.7PubMed Central. Understanding the Warburg effect: the metabolic requirements of cell proliferation
This insight has practical implications for therapy. Forcing cells away from glycolysis with a glucose analog called 2-deoxy-D-glucose (2-DG) was shown to inhibit the migration and invasive behavior of highly metastatic cancer cells at doses that were not directly toxic.8PubMed. Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo In a mouse model of ovarian cancer, administering 2-DG as maintenance after conventional chemotherapy slowed recurrent tumor growth, suggesting potential value as a follow-up strategy rather than a standalone treatment.9PubMed Central. Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors Glycolysis inhibitors remain largely experimental, but the idea that metabolism itself can be a therapeutic target has opened a real area of drug development.
Red Blood Cells and the Price of Losing Mitochondria
Mature red blood cells in mammals are unusual: they have ejected their mitochondria. Without mitochondria, there is no oxygen-dependent energy extraction. That means glycolysis is not just the fast option for red blood cells; it is the only option. Everything the red blood cell does to maintain itself, keeping its membrane flexible, running ion pumps, protecting itself from oxidative damage, depends on the two ATP per glucose that glycolysis provides.10Blood. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis
This total dependence makes red blood cells especially vulnerable to inherited enzyme defects in the glycolytic pathway. Pyruvate kinase deficiency, the most common such defect, is caused by mutations in the PKLR gene and leads to chronic hemolytic anemia. The severity varies dramatically, from barely noticeable to life-threatening in newborns, depending on which specific mutations a person carries and a range of other genetic and physiological factors.11PubMed. Pyruvate kinase deficiency: the genotype-phenotype association The condition is inherited in a recessive pattern, so symptoms typically appear only when someone has two faulty copies of the gene.12PubMed Central. Updates and advances in pyruvate kinase deficiency
Glycolysis in the Brain
The brain is one of the most energy-hungry organs in the body, consuming roughly a fifth of your resting energy. It relies overwhelmingly on glucose, but the way that glucose gets used involves a surprising division of labor between two cell types. Astrocytes, the star-shaped support cells that surround neurons, take up glucose and run it through glycolysis, releasing lactate. Nearby neurons then absorb that lactate and feed it into their own mitochondria for efficient energy production. This arrangement, called the astrocyte-neuron lactate shuttle, was proposed in the 1990s and has since become a central framework for understanding brain energy metabolism.13PubMed Central. Brain energy homeostasis: the evolution of the astrocyte-neuron lactate shuttle hypothesis
The process is tied directly to neural activity. When a neuron fires, the released neurotransmitter glutamate is taken up by neighboring astrocytes. That uptake triggers a chain of events inside the astrocyte that ramps up glucose import and glycolysis, increasing lactate output precisely where and when neurons need fuel.14Cell Metabolism. Brain Energy Metabolism and the Intercellular Transfer of Energy Substrates The brain, then, does not just passively consume glucose. It uses glycolysis in a coordinated, cell-type-specific way to match energy supply to the second-by-second demands of thought.
Immune Cells and the Glycolytic Switch
When your immune system detects an infection, certain white blood cells undergo a dramatic metabolic shift. Pro-inflammatory immune cells, including a type of macrophage and several kinds of T cells, ramp up glycolysis and lactate production even when oxygen is available, in a manner that parallels the Warburg effect in cancer cells. The logic is similar: rapid glycolysis provides both the quick energy and the biosynthetic raw materials these cells need to proliferate and mount an inflammatory response.15PubMed Central. Glycolysis – a key player in the inflammatory response This makes glycolysis more than just a metabolic pathway in the immune context. It acts as a kind of metabolic switch that shapes whether and how strongly the immune system responds.
Fructose and Other Sugars Entering the Pathway
Glucose is the canonical starting material, but the body also processes other sugars through glycolysis. Fructose, for example, enters at a slightly different point. The enzyme fructokinase phosphorylates fructose much more readily than glucokinase handles glucose, which means fructose bypasses the phosphofructokinase checkpoint and floods the lower half of the pathway with three-carbon intermediates. Despite that difference, the pathways of fructose and glucose metabolism converge at the level of these three-carbon intermediates, so the downstream chemistry is the same.16BioMed Central / PubMed Central. Fructose in perspective Galactose, from dairy, also feeds into the pathway after being converted to a glucose derivative. The glycolytic pathway, in practice, is a funnel for most dietary sugars.
A Toxic Byproduct You Rarely Hear About
Glycolysis has a messy side that rarely gets mentioned in introductory biology. One of the three-carbon intermediates can spontaneously break down into methylglyoxal, a highly reactive compound that sticks to proteins and DNA, forming what are called advanced glycation end products. Cells normally mop up methylglyoxal with a cleanup system called the glyoxalase pathway, converting it into harmless D-lactate.17Clinical Science. The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases But when glycolysis runs at high rates, as it does in diabetes or in rapidly growing tumors, methylglyoxal can overwhelm the cleanup system. The resulting protein damage has been linked to complications of diabetes and to aging-related diseases. This is one reason why chronically elevated blood sugar causes harm beyond simple calorie excess: the glycolytic pathway itself generates a damaging waste product when running in overdrive.
Moonlighting Enzymes
For decades, glycolytic enzymes were considered “housekeeping” proteins, doing one job and doing it the same way in every cell. That view has been overturned. Many glycolytic enzymes turn out to have secondary roles that have nothing to do with breaking down sugar. They participate in controlling cell growth, programmed cell death, gene expression, and even immune signaling.18PubMed Central. Moonlight functions of glycolytic enzymes in cancer Pyruvate kinase, the final enzyme in the pathway, does not just make pyruvate; it also plays a role in regulating how a cell allocates resources between energy production and biosynthesis.19PubMed Central. Pyruvate kinase: Function, regulation and role in cancer These moonlighting activities help explain why mutations in glycolytic genes often have effects far more complicated than simply slowing down sugar metabolism.
Physical Organization Inside the Cell
Textbook diagrams show glycolysis as a sequence of freely floating enzymes bumping into substrates by chance. Reality looks different. Recent work in yeast has shown that glycolytic enzymes form highly dynamic clusters that researchers have described as “protein flocks,” constantly assembling and disassembling rather than existing as stable complexes.20Nature Communications. Highly dynamic assemblies of glycolytic enzymes by quinary determinants In mammalian cells, there is evidence that glycolytic enzymes can organize into a functional unit on the outer surface of mitochondria. A sugar-based chemical modification on hexokinase, the first enzyme in the pathway, promotes the assembly of this complex, which coordinates glycolytic output with mitochondrial energy production.21Nature Metabolism. Organization of a functional glycolytic metabolon on mitochondria for metabolic efficiency The pathway, it seems, is not just a list of reactions; it is a physically organized machine that can be assembled where and when the cell needs it most.
Glycolysis in Plants
Plant cells run glycolysis in two separate compartments: the main cell interior and the plastid, which in green cells is the chloroplast. The two copies of the pathway use distinct versions of each enzyme, encoded by different genes.22PubMed. THE ORGANIZATION AND REGULATION OF PLANT GLYCOLYSIS This arrangement makes sense when you consider that photosynthetic cells and non-green cells, like root cells, have very different energy and raw-material needs.23PubMed Central. The specific role of plastidial glycolysis in photosynthetic and heterotrophic cells under scrutiny through the study of glyceraldehyde-3-phosphate dehydrogenase A leaf cell performing photosynthesis is swimming in sugar and three-carbon intermediates; a root cell buried in soil is importing sugar from above. The dual-compartment setup lets each part of the cell tune glycolysis independently for its own local purposes.
An Ancient Pathway That May Have Run Backward First
Glycolysis is found in virtually every organism alive today, from the simplest bacteria to humans, which makes it one of the oldest metabolic pathways in existence.24PubMed. Hidden biochemical fossils reveal an evolutionary trajectory for glycolysis in the prebiotic era But there is a twist in the evolutionary story. The middle section of the pathway, sometimes called trunk glycolysis, appears to be conserved not because of its role in breaking down sugar but because of its role running in the opposite direction, building three-carbon backbones needed for amino acids, nucleotide bases, and cofactors. The data suggest that glycolysis originated as a biosynthetic pathway, assembling molecules rather than dismantling glucose. The glycogen storage molecule, which serves as the starting material for glycolysis in many organisms, appears to have been present in the last common ancestors of bacteria and archaea, and possibly in the last universal common ancestor of all life.25PubMed Central. The early evolution of the glycolytic pathway from autotrophic origins to glycogen and back Even some modern organisms that are strictly autotrophic and cannot import glucose from the environment still synthesize glycogen internally and break it down through glycolysis. The pathway we think of as sugar-burning may have started life as a sugar-building road, and only later got repurposed for energy extraction.